Furthermore, Hashimoto et al. found that a selective α7nAChRs agonist attenuates atherogenesis and AAA formation in ApoE−/− mice, supporting the anti-inflammatory capabilities of α7nAChRs [52]. Here, APOE is linked to triple-A syndrome.